1. Home
  2. GTLB vs ALKS Comparison

GTLB vs ALKS Comparison

Compare GTLB & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GitLab Inc.

GTLB

GitLab Inc.

HOLD

Current Price

$26.31

Market Cap

6.0B

Sector

Technology

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$30.21

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTLB
ALKS
Founded
2011
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.5B
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
GTLB
ALKS
Price
$26.31
$30.21
Analyst Decision
Buy
Buy
Analyst Count
27
14
Target Price
$49.35
$43.43
AVG Volume (30 Days)
5.4M
1.6M
Earning Date
03-04-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
98.55
N/A
EPS
N/A
1.43
Revenue
$759,249,000.00
$1,475,899,000.00
Revenue This Year
$27.21
$24.94
Revenue Next Year
$18.86
$3.47
P/E Ratio
N/A
$21.03
Revenue Growth
30.93
N/A
52 Week Low
$23.45
$25.17
52 Week High
$64.42
$36.32

Technical Indicators

Market Signals
Indicator
GTLB
ALKS
Relative Strength Index (RSI) 36.13 38.26
Support Level N/A $27.77
Resistance Level $50.47 $31.69
Average True Range (ATR) 1.78 1.12
MACD -0.06 -0.50
Stochastic Oscillator 30.22 19.26

Price Performance

Historical Comparison
GTLB
ALKS

About GTLB GitLab Inc.

GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: